Doximity Inc. (DOCS) earns a Roarable Rating of B- (Buy) with 70/100 RQD Confidence. High-quality cash engine (89% profit margin, 17% return on capital) with steady institutional support. Even if the broader market gets choppy, the company’s underlying cash engine and big-money support put the odds in buyers’ favor.
Doximity Inc. (DOCS) slipped -1.81% to $33.63 as options desks priced 51% call premium vs. 49% put protection around the $33 max-pain magnet. High-quality cash engine (89% profit margin, 17% return on capital) with steady institutional support.
Tempus AI or Doximity: Which medical information systems stock offers better value? Compare growth prospects, AI expansion, earnings estimates and valuation.
Doximity (DOCS) closed the most recent trading day at $33.63, moving 1.81% from the previous trading session.
SAN FRANCISCO, October 29, 2026--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, has launched DoseCheck, a free additional safety layer in Doximity Ask that instantly checks ever
Wolters Kluwer shares have climbed sharply in the past month, which puts fresh attention on a basic question for anyone watching the stock. Is the current price properly supported by the earnings the business is generati
Doximity’s updated analyst work now anchors around a fair value estimate of US$30.94, up from US$29.67, which fine tunes where some investors may see the stock’s long term potential. The shift comes as recent research hi
Check out the companies making headlines yesterday:
Doximity is a clear winner in key fundamentals like 5-year revenue CAGR, ROCE, and profit margin. Find out why DOCS stock is a buy.
Shares of medical professional network Doximity (NYSE:DOCS) jumped 7.3% in the afternoon session after the company announced a partnership with Wolters Kluwer Health to integrate UpToDate clinical content into its Doximi
The health AI companies are putting to bed a legal dispute involving dueling lawsuits, claims of corporate espionage and allegations of harassment.
SAN FRANCISCO & WALTHAM, Mass., October 20, 2026--Doximity (NYSE: DOCS), the leading digital platform for U.S. medical professionals, and Wolters Kluwer Health, today announced that UpToDate’s trusted, evidence-based, cl
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +13.1% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on DOCS today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for DOCS. Explore sector supply chains on /butterfly.
Why DOCS Stock slipped -1.81% Today — RQD Quant Desk Flash. High-quality cash engine (89% profit margin, 17% return on capital) with steady institutional support.